2009
DOI: 10.1016/j.seizure.2009.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Variable neurologic phenotype in a GEFS+ family with a novel mutation in SCN1A

Abstract: A novel missense mutation in the pore-forming region of the sodium channel gene SCN1A causes GEFS+ with a variable phenotype that includes mood and anxiety disorders, as well as ataxia, expanding the GEFS+ spectrum to include neuropsychiatric disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 32 publications
0
21
0
1
Order By: Relevance
“…1D). Mutations in SCN1A are also linked to social deficits in idiopathic autism, GEFS+, and DS (Li et al, 2011; Mahoney et al, 2009; Weiss et al, 2003), and DS/B6 mice exhibited social interaction deficits when tested in the three-chamber paradigm (Han et al, 2012a). Likewise, DS/129 mice also had social interaction deficits (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…1D). Mutations in SCN1A are also linked to social deficits in idiopathic autism, GEFS+, and DS (Li et al, 2011; Mahoney et al, 2009; Weiss et al, 2003), and DS/B6 mice exhibited social interaction deficits when tested in the three-chamber paradigm (Han et al, 2012a). Likewise, DS/129 mice also had social interaction deficits (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…In addition to seizures, patients with SCN1A mutations also manifest behavioral comorbidities such as attention-deficit disorder (ADHD)/hyperactivity, deficits in learning and memory, autistic behaviors and motor impairments (Wolff et al 2006, Mahoney et al 2009, Brunklaus et al 2011, Genton et al 2011, Li et al 2011, Ragona 2011, Tan et al 2012). However, the association between recurrent and prolonged early-life FSs and the development of these clinically challenging phenotypes in patients with SCN1A mutations remains unclear and has never been experimentally investigated.…”
Section: Discussionmentioning
confidence: 99%
“…The link between molecular deficit and clinical phenotype, however, is poorly characterized due to clinical heterogeneity in familial epilepsies that is thought to arise from differences in genetic background (Osaka et al 2007;Mahoney et al 2009). In SCN1A, lesions that result in truncated proteins are almost always associated with the intractable disorders severe myoclonic epilepsy in infants (SMEI) or intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC).…”
Section: Discussionmentioning
confidence: 99%